Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism.

[1]  A. Miyauchi,et al.  Serum concentrations of remnant‐like particles in hypothyroid patients before and after thyroxine replacement , 2003, Clinical endocrinology.

[2]  E. Ferrannini,et al.  Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  J. Drewe,et al.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). , 2001, The Journal of clinical endocrinology and metabolism.

[4]  D. Cooper.  Clinical practice. Subclinical hypothyroidism. , 2001, The New England journal of medicine.

[5]  H. Koppeschaar,et al.  Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  N. Powe,et al.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. , 2000, The Journal of clinical endocrinology and metabolism.

[7]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[8]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[9]  T. McLaughlin,et al.  Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  E. Grossi,et al.  Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area , 1999, Journal of endocrinological investigation.

[11]  T. Taniguchi,et al.  Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. , 1999, Diabetes care.

[12]  K. Kugiyama,et al.  Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. , 1998, Circulation.

[13]  D. Bauer,et al.  Thyroid Function and Serum Lipids in Older Women: A Population-based Study , 1998 .

[14]  S. Grundy,et al.  Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. , 1998, The American journal of medicine.

[15]  M. Ozata,et al.  Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. , 1996, Endocrine journal.

[16]  C. Franceschi,et al.  The aging thyroid. , 1995, Endocrine reviews.

[17]  E. Janus,et al.  Elevated serum lipoprotein(a) in subclinical hypothyroidism , 1995, Clinical endocrinology.

[18]  R. Havel.  Postprandial hyperlipidemia and remnant lipoproteins. , 1994, Current opinion in lipidology.

[19]  K. Nakajima,et al.  Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[20]  D. Waters,et al.  Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events , 1993, Circulation.

[21]  B. Weintraub,et al.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. , 1992, The American journal of medicine.

[22]  R. Havel,et al.  Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. , 1992, Journal of lipid research.

[23]  P. Thompson.  CORONARY THROMBOLYSIS AND MYOCARDIAL SALVAGE BY TISSUE PLASMINOGEN ACTIVATOR , 1988, The Lancet.

[24]  P. Fowler,et al.  Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. , 1985, British medical journal.

[25]  F. Azizi,et al.  The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. , 1979, JAMA.

[26]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.

[27]  L. Vanhaelst,et al.  Preclinical hypothyroidism: a risk factor for coronary heart-disease. , 1971, Lancet.

[28]  J. Little,et al.  A comparison of laboratory screening procedures for hyperlipidemia. , 1969, Clinica chimica acta; international journal of clinical chemistry.